![](https://www.molecular-medicine-israel.co.il/wp-content/uploads/2020/03/CRISPR-clinical-trials-1-300x188.jpg)
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
Abstract Harnessing CRISPR-Cas9 technology for cancer therapeutics has been hampered by low editing efficiency in tumors and potential toxicity of existing delivery systems. Here, we